Abiraterone
The serum concentration of Propranolol can be increased when it is combined with Abiraterone.
Acebutolol
Propranolol may increase the hypotensive activities of Acebutolol.
Aceclofenac
Aceclofenac may decrease the antihypertensive activities of Propranolol.
Advertisement
Acemetacin
The therapeutic efficacy of Propranolol can be decreased when used in combination with Acemetacin.
Acepromazine
Propranolol may increase the orthostatic hypotensive activities of Acepromazine.
Aceprometazine
Aceprometazine may increase the hypotensive activities of Propranolol.
Advertisement
Acetohexamide
Propranolol may increase the hypoglycemic activities of Acetohexamide.
Acetyl salicylate
Acetylsalicylic acid may decrease the antihypertensive activities of Propranolol.
Acetyl Sulfisoxazole
The metabolism of Propranolol can be decreased when combined with Acetyl sulfisoxazole.
Advertisement
Acetylcholine
The risk or severity of adverse effects can be increased when Propranolol is combined with Acetylcholine.
Acetylcholine Chloride
The risk or severity of adverse effects can be increased when Propranolol is combined with Acetylcholine.
Acetyldigitoxin
Propranolol may increase the bradycardic activities of Acetyldigitoxin.
Adapalene
Adapalene may decrease the antihypertensive activities of Propranolol.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Propranolol.
Albuterol
Propranolol may decrease the bronchodilatory activities of Salbutamol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Propranolol.
Alfentanil
Alfentanil may increase the bradycardic activities of Propranolol.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Propranolol.
Aliskiren
Propranolol may increase the hypotensive activities of Aliskiren.
Alminoprofen
Alminoprofen may decrease the antihypertensive activities of Propranolol.
Alprenolol
Propranolol may increase the hypotensive activities of Alprenolol.
Ambenonium
Ambenonium may increase the bradycardic activities of Propranolol.
Ambrisentan
Propranolol may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
Propranolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Ambroxol-Theophylline-7-Acetate
Propranolol may decrease the bronchodilatory activities of Ambroxol acefyllinate.
Amifostine
Propranolol may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Propranolol may increase the hypotensive activities of Amifostine.
Amiloride
The risk or severity of adverse effects can be increased when Propranolol is combined with Amiloride.
Aminophylline
Propranolol may decrease the bronchodilatory activities of Aminophylline.
Amiodarone
The therapeutic efficacy of Propranolol can be increased when used in combination with Amiodarone.
Amitriptyline
Propranolol may increase the orthostatic hypotensive activities of Amitriptyline.
Amlodipine
Amlodipine may increase the hypotensive activities of Propranolol.
Amobarbital
The serum concentration of Propranolol can be decreased when it is combined with Amobarbital.
Amodiaquine
The metabolism of Propranolol can be decreased when combined with Amodiaquine.
Amoxapine
Propranolol may increase the orthostatic hypotensive activities of Amoxapine.
Amphetamine
Amphetamine may increase the hypotensive activities of Propranolol.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Propranolol.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Propranolol.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Propranolol is combined with Amyl Nitrite.
Antipyrine
Antipyrine may decrease the antihypertensive activities of Propranolol.
Apalutamide
The serum concentration of Propranolol can be decreased when it is combined with Apalutamide.
Apazone
Azapropazone may decrease the antihypertensive activities of Propranolol.
Apomorphine
Apomorphine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Apraclonidine
The risk or severity of adverse effects can be increased when Propranolol is combined with Apraclonidine.
Apremilast
Apremilast may decrease the antihypertensive activities of Propranolol.
Aprepitant
The serum concentration of Propranolol can be increased when it is combined with Aprepitant.
Arbutamine
Propranolol may decrease the bronchodilatory activities of Arbutamine.
Arformoterol
Propranolol may decrease the bronchodilatory activities of Arformoterol.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Propranolol.
Armodafinil
The metabolism of Propranolol can be decreased when combined with Armodafinil.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Propranolol.
Artemether
The metabolism of Propranolol can be decreased when combined with Artemether.
Asenapine
Propranolol may increase the orthostatic hypotensive activities of Asenapine.
Aspirin
Acetylsalicylic acid may decrease the antihypertensive activities of Propranolol.
Atazanavir
The metabolism of Propranolol can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the hypotensive activities of Propranolol.
Atomoxetine
The metabolism of Propranolol can be decreased when combined with Atomoxetine.
Avanafil
Avanafil may increase the antihypertensive activities of Propranolol.
Azelastine
Azelastine may decrease the antihypertensive activities of Propranolol.
Azilsartan
The risk or severity of adverse effects can be increased when Propranolol is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Propranolol is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Propranolol is combined with Azilsartan medoxomil.
Azithromycin
The metabolism of Propranolol can be decreased when combined with Azithromycin.
Balsalazide
Balsalazide may decrease the antihypertensive activities of Propranolol.
Bambuterol
Propranolol may decrease the bronchodilatory activities of Bambuterol.
Barbexaclone
The serum concentration of Propranolol can be decreased when it is combined with Barbexaclone.
Barbital
The serum concentration of Propranolol can be decreased when it is combined with Barbital.
Benazepril
Benazepril may increase the hypotensive activities of Propranolol.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Propranolol.
Benzphetamine
Benzphetamine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Benzydamine
Benzydamine may decrease the antihypertensive activities of Propranolol.
Bepridil
Propranolol may increase the hypotensive activities of Bepridil.
Beractant
Propranolol may increase the bradycardic activities of Beractant.
Betaxolol
The metabolism of Propranolol can be decreased when combined with Betaxolol.
Bethanechol
The risk or severity of adverse effects can be increased when Propranolol is combined with Bethanechol.
Bethanidine
Bethanidine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Bimatoprost
Propranolol may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Propranolol may increase the hypotensive activities of Bisoprolol.
Bitolterol
Propranolol may decrease the bronchodilatory activities of Bitolterol.
Bitolterol Mesylate
Propranolol may decrease the bronchodilatory activities of Bitolterol.
Boceprevir
The metabolism of Propranolol can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Propranolol can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Propranolol can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Propranolol can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Propranolol.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Propranolol.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Propranolol.
Bretylium
Bretylium may increase the bradycardic activities of Propranolol.
Brexpiprazole
Propranolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Brimonidine
Brimonidine may increase the antihypertensive activities of Propranolol.
Bromfenac
Bromfenac may decrease the antihypertensive activities of Propranolol.
Bromocriptine
Bromocriptine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Bufexamac
Bufexamac may decrease the antihypertensive activities of Propranolol.
Bumetanide
The risk or severity of adverse effects can be increased when Propranolol is combined with Bumetanide.
Bunazosin
Propranolol may increase the orthostatic hypotensive activities of Bunazosin.
Bupivacaine
The serum concentration of Bupivacaine can be increased when it is combined with Propranolol.
Bupranolol
Propranolol may increase the hypotensive activities of Bupranolol.
Bupropion
The metabolism of Propranolol can be decreased when combined with Bupropion.
Cabergoline
Propranolol may increase the vasoconstricting activities of Cabergoline.
Cafedrine
Propranolol may increase the hypotensive activities of Cafedrine.
Caffeine
The metabolism of Propranolol can be decreased when combined with Caffeine.
Calfactant
Propranolol may increase the bradycardic activities of Calfactant.
Canagliflozin
The risk or severity of adverse effects can be increased when Propranolol is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Propranolol is combined with Canagliflozin.
Candesartan
Propranolol may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Propranolol may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Propranolol may increase the hypotensive activities of Captopril.
Carbachol
The risk or severity of adverse effects can be increased when Propranolol is combined with Carbachol.
Carbamazepine
The metabolism of Propranolol can be increased when combined with Carbamazepine.
Carprofen
Carprofen may decrease the antihypertensive activities of Propranolol.
Carteolol
Carteolol may increase the hypotensive activities of Propranolol.
Carvedilol
Propranolol may increase the orthostatic hypotensive activities of Carvedilol.
Celecoxib
The metabolism of Propranolol can be decreased when combined with Celecoxib.
Celiprolol
Propranolol may decrease the bronchodilatory activities of Celiprolol.
Ceritinib
Propranolol may increase the bradycardic activities of Ceritinib.
Cevimeline
The risk or severity of adverse effects can be increased when Propranolol is combined with Cevimeline.
Chloramphenicol
The metabolism of Propranolol can be decreased when combined with Chloramphenicol.
Chloroquine
The metabolism of Propranolol can be decreased when combined with Chloroquine.
Chlorothiazide
Propranolol may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
Propranolol may increase the orthostatic hypotensive activities of Chlorpromazine.
Chlorpropamide
Propranolol may increase the hypoglycemic activities of Chlorpropamide.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Propranolol.
Cholecalciferol
The metabolism of Propranolol can be decreased when combined with Cholecalciferol.
Cholestyramine Resin
The serum concentration of Propranolol can be decreased when it is combined with Cholestyramine.
Choline Magnesium Trisalicyclate
Choline magnesium trisalicylate may decrease the antihypertensive activities of Propranolol.
Cicletanine
Propranolol may increase the hypotensive activities of Cicletanine.
Cilazapril
Propranolol may increase the hypotensive activities of Cilazapril.
Cimetidine
The metabolism of Propranolol can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Propranolol can be decreased when combined with Cinacalcet.
Citalopram
The metabolism of Propranolol can be decreased when combined with Citalopram.
Clarithromycin
The metabolism of Propranolol can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Propranolol can be decreased when combined with Clemastine.
Clenbuterol
Propranolol may decrease the bronchodilatory activities of Clenbuterol.
Clevidipine
The risk or severity of adverse effects can be increased when Propranolol is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Propranolol is combined with Clevidipine.
Clobazam
The metabolism of Propranolol can be decreased when combined with Clobazam.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Propranolol.
Clomipramine
The metabolism of Propranolol can be decreased when combined with Clomipramine.
Clonidine
Clonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Clonixin
Clonixin may decrease the antihypertensive activities of Propranolol.
Clotrimazole
The metabolism of Propranolol can be decreased when combined with Clotrimazole.
Clozapine
Propranolol may increase the orthostatic hypotensive activities of Clozapine.
Cobicistat
The serum concentration of Propranolol can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Propranolol can be decreased when combined with Cocaine.
coenzyme Q10
The therapeutic efficacy of Ubidecarenone can be decreased when used in combination with Propranolol.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Propranolol.
Colesevelam
The serum concentration of Propranolol can be decreased when it is combined with Colesevelam.
Colestipol
The serum concentration of Propranolol can be decreased when it is combined with Colestipol.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Propranolol.
Crizotinib
The metabolism of Propranolol can be decreased when combined with Crizotinib.
Cryptenamine
Propranolol may increase the hypotensive activities of Cryptenamine.
Curcumin
The metabolism of Propranolol can be decreased when combined with Curcumin.
Cyclopenthiazide
Propranolol may increase the hypotensive activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Propranolol can be decreased when combined with Cyclosporine.
Cyclothiazide
Propranolol may increase the hypotensive activities of Cyclothiazide.
Cyproterone Acetate
The serum concentration of Propranolol can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Propranolol.
Dabrafenib
The serum concentration of Propranolol can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Propranolol is combined with Dapagliflozin.
Dapiprazole
Propranolol may increase the orthostatic hypotensive activities of Dapiprazole.
Darifenacin
The metabolism of Propranolol can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Propranolol can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Propranolol can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Propranolol can be increased when it is combined with Dasatinib.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Propranolol.
Deferasirox
The serum concentration of Propranolol can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Propranolol can be decreased when combined with Delavirdine.
Demecarium
Demecarium may increase the bradycardic activities of Propranolol.
Deserpidine
Propranolol may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Propranolol.
Desipramine
The metabolism of Propranolol can be decreased when combined with Desipramine.
Deslanoside
Propranolol may increase the bradycardic activities of Deslanoside.
Desvenlafaxine
The serum concentration of Propranolol can be increased when it is combined with Desvenlafaxine.
Dexmedetomidine
Dexmedetomidine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Dextroamphetamine
Propranolol may increase the orthostatic hypotensive activities of Dextroamphetamine.
Diazoxide
Diazoxide may increase the hypotensive activities of Propranolol.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Propranolol is combined with Diclofenamide.
Diclofenac
Diclofenac may decrease the antihypertensive activities of Propranolol.
Diflunisal
Diflunisal may decrease the antihypertensive activities of Propranolol.
Digitoxin
Propranolol may increase the bradycardic activities of Digitoxin.
Digoxin
Propranolol may increase the bradycardic activities of Digoxin.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Propranolol.
Dihydroergotamine
Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Diltiazem
The metabolism of Propranolol can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Propranolol is combined with Dinutuximab.
Diphenhydramine
The metabolism of Propranolol can be decreased when combined with Diphenhydramine.
Dipivefrin
Propranolol may decrease the bronchodilatory activities of Dipivefrin.
Dipyridamole
Dipyridamole may increase the bradycardic activities of Propranolol.
Dipyrone
Metamizole may decrease the antihypertensive activities of Propranolol.
Disopyramide
Disopyramide may increase the bradycardic activities of Propranolol.
Distigmine
Distigmine may increase the bradycardic activities of Propranolol.
Dobutamine
Propranolol may decrease the bronchodilatory activities of Dobutamine.
Donepezil
Donepezil may increase the bradycardic activities of Propranolol.
Dorzolamide
Propranolol may increase the hypotensive activities of Dorzolamide.
Dothiepin
The metabolism of Propranolol can be decreased when combined with Dosulepin.
Doxazosin
Propranolol may increase the orthostatic hypotensive activities of Doxazosin.
Doxepin
Propranolol may increase the orthostatic hypotensive activities of Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Propranolol.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Propranolol.
Doxycycline
The metabolism of Propranolol can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Propranolol can be decreased when combined with Doxycycline.
Dronedarone
Dronedarone may increase the bradycardic activities of Propranolol.
Droperidol
Propranolol may increase the orthostatic hypotensive activities of Droperidol.
Droxicam
Droxicam may decrease the antihypertensive activities of Propranolol.
Droxidopa
Propranolol may decrease the bronchodilatory activities of Droxidopa.
Duloxetine
Propranolol may increase the orthostatic hypotensive activities of Duloxetine.
Dyphylline
Propranolol may decrease the bronchodilatory activities of Dyphylline.
Echothiophate
Echothiophate may increase the bradycardic activities of Propranolol.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Propranolol.
Edrophonium
Edrophonium may increase the bradycardic activities of Propranolol.
Efavirenz
The metabolism of Propranolol can be decreased when combined with Efavirenz.
Eliglustat
The metabolism of Propranolol can be decreased when combined with Eliglustat.
Empagliflozin
The risk or severity of adverse effects can be increased when Propranolol is combined with Empagliflozin.
Enalapril
Propranolol may increase the hypotensive activities of Enalapril.
Enalaprilat
Propranolol may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Propranolol may increase the hypotensive activities of Enalaprilat.
Enzalutamide
The serum concentration of Propranolol can be decreased when it is combined with Enzalutamide.
Epinephrine
Propranolol may decrease the bronchodilatory activities of Epinephrine.
Eplerenone
The risk or severity of adverse effects can be increased when Propranolol is combined with Eplerenone.
Epoprostenol
Propranolol may increase the hypotensive activities of Epoprostenol.
Eprosartan
Propranolol may increase the hypotensive activities of Eprosartan.
ergoloid mesylates, USP
Propranolol may increase the vasoconstricting activities of Ergoloid mesylate.
Ergonovine
Propranolol may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Erythromycin
The metabolism of Propranolol can be decreased when combined with Erythromycin.
Escitalopram
Propranolol may increase the orthostatic hypotensive activities of Escitalopram.
Eslicarbazepine Acetate
The metabolism of Propranolol can be decreased when combined with Eslicarbazepine acetate.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Propranolol.
Esomeprazole
The metabolism of Propranolol can be decreased when combined with Esomeprazole.
Etanercept
Etanercept may decrease the antihypertensive activities of Propranolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Propranolol is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Propranolol is combined with Etacrynic acid.
Ethanol
The serum concentration of Propranolol can be decreased when it is combined with Ethanol.
Etodolac
Etodolac may decrease the antihypertensive activities of Propranolol.
Etofenamate
Etofenamate may decrease the antihypertensive activities of Propranolol.
Etomidate
Etomidate may increase the atrioventricular blocking (AV block) activities of Propranolol.
Etoricoxib
Etoricoxib may decrease the antihypertensive activities of Propranolol.
Etravirine
The metabolism of Propranolol can be decreased when combined with Etravirine.
Evening primrose oil
Evening primrose oil may decrease the antihypertensive activities of Propranolol.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Propranolol.
Felbinac
Felbinac may decrease the antihypertensive activities of Propranolol.
Felodipine
Propranolol may increase the hypotensive activities of Felodipine.
Fenbufen
Fenbufen may decrease the antihypertensive activities of Propranolol.
Fenoldopam
Propranolol may increase the hypotensive activities of Fenoldopam.
Fenoprofen
Fenoprofen may decrease the antihypertensive activities of Propranolol.
Fenoterol
Propranolol may decrease the bronchodilatory activities of Fenoterol.
Fentanyl
Fentanyl may increase the bradycardic activities of Propranolol.
Ferulic Acid
Propranolol may increase the hypotensive activities of Ferulic acid.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Propranolol.
Fingolimod
Propranolol may increase the bradycardic activities of Fingolimod.
Floctafenine
The risk or severity of adverse effects can be increased when Propranolol is combined with Floctafenine.
Fluconazole
The metabolism of Propranolol can be decreased when combined with Fluconazole.
Fluoxetine
The metabolism of Propranolol can be decreased when combined with Fluoxetine.
Flupenthixol
Propranolol may increase the orthostatic hypotensive activities of Flupentixol.
Fluphenazine
Fluphenazine may increase the hypotensive activities of Propranolol.
Flurbiprofen
Flurbiprofen may decrease the antihypertensive activities of Propranolol.
Fluvoxamine
The serum concentration of Propranolol can be increased when it is combined with Fluvoxamine.
Formoterol
Propranolol may decrease the bronchodilatory activities of Formoterol.
Fosamprenavir
The metabolism of Propranolol can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Propranolol can be increased when it is combined with Fosaprepitant.
Fosinopril
Fosinopril may increase the hypotensive activities of Propranolol.
Fosphenytoin
The metabolism of Propranolol can be increased when combined with Fosphenytoin.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Propranolol.
Furazolidone
Furazolidone may increase the hypotensive activities of Propranolol.
Furosemide
The risk or severity of adverse effects can be increased when Propranolol is combined with Furosemide.
Fusidate
The serum concentration of Propranolol can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Propranolol can be increased when it is combined with Fusidic Acid.
Galantamine
Galantamine may increase the bradycardic activities of Propranolol.
Gallamine Triethiodide
Gallamine Triethiodide may increase the bradycardic activities of Propranolol.
Gemfibrozil
The metabolism of Propranolol can be decreased when combined with Gemfibrozil.
Ginkgo biloba extract
Ginkgo biloba may increase the bradycardic activities of Propranolol.
Glibornuride
Propranolol may increase the hypoglycemic activities of Glibornuride.
Gliclazide
Propranolol may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Propranolol may increase the hypoglycemic activities of Glimepiride.
Glipizide
Propranolol may increase the hypoglycemic activities of Glipizide.
Gliquidone
Propranolol may increase the hypoglycemic activities of Gliquidone.
Glyburide
Propranolol may increase the hypoglycemic activities of Glyburide.
Guanabenz
Guanabenz may increase the atrioventricular blocking (AV block) activities of Propranolol.
Guanadrel
Guanadrel may increase the hypotensive activities of Propranolol.
Guanethidine
Propranolol may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Haloperidol
The metabolism of Propranolol can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Propranolol.
Hexobarbital
The serum concentration of Propranolol can be decreased when it is combined with Hexobarbital.
Hexoprenaline
Propranolol may decrease the bronchodilatory activities of Hexoprenaline.
Hydralazine
Hydralazine may increase the hypotensive activities of Propranolol.
Hydrochlorothiazide
Propranolol may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Propranolol may increase the hypotensive activities of Hydroflumethiazide.
Hydroxychloroquine
The metabolism of Propranolol can be decreased when combined with Hydroxychloroquine.
Hypoxis hemerocallidea root extract
The serum concentration of Propranolol can be decreased when it is combined with St. John's Wort.
Ibuprofen
Ibuprofen may decrease the antihypertensive activities of Propranolol.
Icatibant
Icatibant may decrease the antihypertensive activities of Propranolol.
Idelalisib
The metabolism of Propranolol can be decreased when combined with Idelalisib.
Iloperidone
Propranolol may increase the orthostatic hypotensive activities of Iloperidone.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Propranolol.
Imatinib
The metabolism of Propranolol can be decreased when combined with Imatinib.
Imidapril
Propranolol may increase the hypotensive activities of Imidapril.
Imipramine
Propranolol may increase the orthostatic hypotensive activities of Imipramine.
Indacaterol
Propranolol may decrease the bronchodilatory activities of Indacaterol.
Indapamide
Propranolol may increase the hypotensive activities of Indapamide.
Indinavir
The metabolism of Propranolol can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Propranolol can be decreased when combined with Indinavir.
Indobufen
Indobufen may decrease the antihypertensive activities of Propranolol.
Indomethacin
Indomethacin may decrease the antihypertensive activities of Propranolol.
Indoramin
Propranolol may increase the orthostatic hypotensive activities of Indoramin.
insulin human, rDNA origin
Propranolol may increase the hypoglycemic activities of Insulin Human.
Insulin, Pork
Propranolol may increase the hypoglycemic activities of Insulin Pork.
Insulin, Regular, Pork
Propranolol may increase the hypoglycemic activities of Insulin Pork.
Iproniazid
Iproniazid may increase the hypotensive activities of Propranolol.
Irbesartan
Propranolol may increase the hypotensive activities of Irbesartan.
Isavuconazole
The serum concentration of Propranolol can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Propranolol can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Propranolol.
Isoetharine
Propranolol may decrease the bronchodilatory activities of Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Propranolol.
Isoflurophate
Isoflurophate may increase the bradycardic activities of Propranolol.
Isoniazid
The metabolism of Propranolol can be decreased when combined with Isoniazid.
Isoproterenol
Propranolol may decrease the bronchodilatory activities of Isoprenaline.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Propranolol is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Propranolol is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Propranolol is combined with Isoxsuprine.
Isradipine
The metabolism of Propranolol can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Propranolol can be decreased when combined with Itraconazole.
Ivabradine
Propranolol may increase the bradycardic activities of Ivabradine.
Ivacaftor
The serum concentration of Propranolol can be increased when it is combined with Ivacaftor.
Kebuzone
Kebuzone may decrease the antihypertensive activities of Propranolol.
Ketanserin
Ketanserin may increase the hypotensive activities of Propranolol.
Ketoconazole
The metabolism of Propranolol can be decreased when combined with Ketoconazole.
Ketoprofen
Ketoprofen may decrease the antihypertensive activities of Propranolol.
Ketorolac
Ketorolac may decrease the antihypertensive activities of Propranolol.
Labetalol
Propranolol may increase the orthostatic hypotensive activities of Labetalol.
Lacidipine
Lacidipine may increase the hypotensive activities of Propranolol.
Lacosamide
Propranolol may increase the atrioventricular blocking (AV block) activities of Lacosamide.
Lanreotide
Propranolol may increase the bradycardic activities of Lanreotide.
Latanoprost
Propranolol may increase the hypotensive activities of Latanoprost.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Propranolol.
Leflunomide
Leflunomide may decrease the antihypertensive activities of Propranolol.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Propranolol.
Levalbuterol
Propranolol may decrease the bronchodilatory activities of Levosalbutamol.
Levobunolol
The risk or severity of adverse effects can be increased when Propranolol is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Propranolol.
Levodopa
Propranolol may increase the orthostatic hypotensive activities of Levodopa.
Levomilnacipran
The serum concentration of Propranolol can be increased when it is combined with Levomilnacipran.
Levonordefrin
Levonordefrin may increase the atrioventricular blocking (AV block) activities of Propranolol.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Propranolol.
Lidocaine
The serum concentration of Lidocaine can be increased when it is combined with Propranolol.
Limonene, (+)-
(4R)-limonene may decrease the antihypertensive activities of Propranolol.
Lisdexamfetamine
Propranolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Propranolol may increase the orthostatic hypotensive activities of Lisdexamfetamine.
Lisinopril
Propranolol may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Propranolol may increase the hypotensive activities of Lisinopril.
Lobeline
The risk or severity of adverse effects can be increased when Propranolol is combined with Lobeline.
Lofexidine
Lofexidine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Lopinavir
The metabolism of Propranolol can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Propranolol can be decreased when combined with Lorcaserin.
Lornoxicam
Lornoxicam may decrease the antihypertensive activities of Propranolol.
Losartan
Propranolol may increase the hypotensive activities of Losartan.
Lovastatin
The metabolism of Propranolol can be decreased when combined with Lovastatin.
Loxoprofen
Loxoprofen may decrease the antihypertensive activities of Propranolol.
Lucinactant
Propranolol may increase the bradycardic activities of Lucinactant.
Luliconazole
The serum concentration of Propranolol can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Propranolol can be decreased when it is combined with Lumacaftor.
Lumefantrine
The metabolism of Propranolol can be decreased when combined with Lumefantrine.
Macitentan
Propranolol may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
Magnesium salicylate may decrease the antihypertensive activities of Propranolol.
Malathion
Malathion may increase the bradycardic activities of Propranolol.
Manidipine
Propranolol may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Propranolol is combined with Mannitol.
Masoprocol
Masoprocol may decrease the antihypertensive activities of Propranolol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Propranolol.
Meclofenamate
Meclofenamic acid may decrease the antihypertensive activities of Propranolol.
Meclofenamic Acid
Meclofenamic acid may decrease the antihypertensive activities of Propranolol.
Mefenamic Acid
Mefenamic acid may decrease the antihypertensive activities of Propranolol.
Mefloquine
Mefloquine may increase the bradycardic activities of Propranolol.
Meloxicam
Meloxicam may decrease the antihypertensive activities of Propranolol.
Memantine
Memantine may increase the bradycardic activities of Propranolol.
Mephobarbital
The serum concentration of Propranolol can be decreased when it is combined with Methylphenobarbital.
Mepirodipine
Propranolol may increase the antihypertensive activities of Barnidipine.
Mepivacaine
The serum concentration of Mepivacaine can be increased when it is combined with Propranolol.
Mesalamine
Mesalazine may decrease the antihypertensive activities of Propranolol.
Mesoridazine
Mesoridazine may increase the hypotensive activities of Propranolol.
Metaproterenol
Propranolol may decrease the bronchodilatory activities of Orciprenaline.
Methacholine
Propranolol may increase the bronchoconstrictory activities of Methacholine.
Methadone
The metabolism of Propranolol can be decreased when combined with Methadone.
Methamphetamine
Methamphetamine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Methazolamide
The risk or severity of adverse effects can be increased when Propranolol is combined with Methazolamide.
Methohexital
The serum concentration of Propranolol can be decreased when it is combined with Methohexital.
Methotrimeprazine
The metabolism of Propranolol can be decreased when combined with Methotrimeprazine.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Propranolol.
Methyldopa
Methyldopa may increase the atrioventricular blocking (AV block) activities of Propranolol.
METHYLDOPA ANHYDROUS
Methyldopa may increase the atrioventricular blocking (AV block) activities of Propranolol.
Methylene blue
Methylene blue may increase the hypotensive activities of Propranolol.
METHYLEPHEDRINE, DL-
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Methylergonovine
Propranolol may increase the vasoconstricting activities of Methylergometrine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Propranolol.
Metipranolol
Propranolol may increase the hypotensive activities of Metipranolol.
Metoclopramide
Metoclopramide may increase the bradycardic activities of Propranolol.
Metolazone
Metolazone may increase the hypotensive activities of Propranolol.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Propranolol.
Metyrosine
Propranolol may increase the hypotensive activities of Metyrosine.
Mexiletine
The metabolism of Propranolol can be decreased when combined with Mexiletine.
Mibefradil
Propranolol may increase the hypotensive activities of Mibefradil.
Midodrine
Propranolol may increase the bradycardic activities of Midodrine.
Midostaurin
The metabolism of Propranolol can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Propranolol can be increased when it is combined with Mifepristone.
Milnacipran
The serum concentration of Propranolol can be increased when it is combined with Milnacipran.
Minaprine
Minaprine may increase the bradycardic activities of Propranolol.
Minoxidil
Minoxidil may increase the hypotensive activities of Propranolol.
Mirabegron
The metabolism of Propranolol can be decreased when combined with Mirabegron.
Mitotane
The serum concentration of Propranolol can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Propranolol can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Propranolol can be decreased when combined with Modafinil.
Moexipril
Propranolol may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Propranolol.
Moricizine
Moricizine may increase the hypotensive activities of Propranolol.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Propranolol.
Moxonidine
Moxonidine may increase the atrioventricular blocking (AV block) activities of Propranolol.
MYCOPHENOLATE
Mycophenolic acid may decrease the antihypertensive activities of Propranolol.
Mycophenolate Mofetil
Mycophenolate mofetil may decrease the antihypertensive activities of Propranolol.
Mycophenolic Acid
Mycophenolic acid may decrease the antihypertensive activities of Propranolol.
N-methylephedrine
DL-Methylephedrine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Propranolol.
Nabumetone
Nabumetone may decrease the antihypertensive activities of Propranolol.
Nadolol
Propranolol may increase the hypotensive activities of Nadolol.
Naftifine
Naftifine may decrease the antihypertensive activities of Propranolol.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Propranolol.
Naphazoline
Naphazoline may increase the atrioventricular blocking (AV block) activities of Propranolol.
Naproxen
Naproxen may decrease the antihypertensive activities of Propranolol.
Nebivolol
Propranolol may increase the hypotensive activities of Nebivolol.
Nefazodone
The metabolism of Propranolol can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Propranolol can be decreased when combined with Nelfinavir.
Neostigmine
Neostigmine may increase the bradycardic activities of Propranolol.
Nepafenac
Nepafenac may decrease the antihypertensive activities of Propranolol.
Nesiritide
The risk or severity of adverse effects can be increased when Propranolol is combined with Nesiritide.
Netupitant
The serum concentration of Propranolol can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Propranolol can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Propranolol.
Nicardipine
Propranolol may increase the orthostatic hypotensive activities of Nicardipine.
Nicergoline
Propranolol may increase the orthostatic hypotensive activities of Nicergoline.
Nicorandil
Nicorandil may increase the hypotensive activities of Propranolol.
Nicotine
The risk or severity of adverse effects can be increased when Propranolol is combined with Nicotine.
Nicotine Polacrilex
The risk or severity of adverse effects can be increased when Propranolol is combined with Nicotine.
Nifedipine
The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Propranolol.
Niflumic Acid
Niflumic Acid may decrease the antihypertensive activities of Propranolol.
Nilotinib
The metabolism of Propranolol can be decreased when combined with Nilotinib.
Nilvadipine
Propranolol may increase the hypotensive activities of Nilvadipine.
Nimesulide
Nimesulide may decrease the antihypertensive activities of Propranolol.
Nimodipine
Nimodipine may increase the hypotensive activities of Propranolol.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Propranolol.
Nitrendipine
Propranolol may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Propranolol.
Nitroglycerin
The risk or severity of adverse effects can be increased when Propranolol is combined with Nitroglycerin.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Propranolol.
Norepinephrine
Propranolol may decrease the bronchodilatory activities of Norepinephrine.
Nortriptyline
Propranolol may increase the orthostatic hypotensive activities of Nortriptyline.
O-PHENANTHROLINE
1,10-Phenanthroline may increase the bradycardic activities of Propranolol.
Obinutuzumab
Propranolol may increase the hypotensive activities of Obinutuzumab.
Octreotide
Octreotide may increase the bradycardic activities of Propranolol.
Oenothera biennis seed extract
Evening primrose oil may decrease the antihypertensive activities of Propranolol.
Olanzapine
Propranolol may increase the orthostatic hypotensive activities of Olanzapine.
Olaparib
The metabolism of Propranolol can be decreased when combined with Olaparib.
Olmesartan
Olmesartan may increase the hypotensive activities of Propranolol.
Olodaterol
Propranolol may decrease the bronchodilatory activities of Olodaterol.
Olopatadine
Olopatadine may decrease the antihypertensive activities of Propranolol.
Olsalazine
Olsalazine may decrease the antihypertensive activities of Propranolol.
Omeprazole
The metabolism of Propranolol can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Propranolol can be increased when it is combined with Osimertinib.
Ouabain
Propranolol may increase the bradycardic activities of Ouabain.
Ovine Digoxin Immune Fab
Propranolol may increase the bradycardic activities of Digoxin Immune Fab (Ovine).
Oxaprozin
Oxaprozin may decrease the antihypertensive activities of Propranolol.
Oxprenolol
Propranolol may increase the hypotensive activities of Oxprenolol.
Oxymetazoline
Oxymetazoline may increase the atrioventricular blocking (AV block) activities of Propranolol.
Oxyphenbutazone
Oxyphenbutazone may decrease the antihypertensive activities of Propranolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Propranolol.
Palbociclib
The serum concentration of Propranolol can be increased when it is combined with Palbociclib.
Paliperidone
Paliperidone may increase the atrioventricular blocking (AV block) activities of Propranolol.
Palmidrol
Palmidrol may decrease the antihypertensive activities of Propranolol.
Panobinostat
The serum concentration of Propranolol can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Propranolol can be decreased when combined with Pantoprazole.
Papaverine
The risk or severity of adverse effects can be increased when Propranolol is combined with Papaverine.
Parecoxib
Parecoxib may decrease the antihypertensive activities of Propranolol.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Propranolol.
Pargyline
Pargyline may increase the hypotensive activities of Propranolol.
Paroxetine
The metabolism of Propranolol can be decreased when combined with Paroxetine.
Parthenolide
Parthenolide may decrease the antihypertensive activities of Propranolol.
Pasireotide
Propranolol may increase the bradycardic activities of Pasireotide.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Propranolol.
Peginterferon Alfa-2b
The serum concentration of Propranolol can be decreased when it is combined with Peginterferon alfa-2b.
Penbutolol
Propranolol may increase the hypotensive activities of Penbutolol.
Pentobarbital
The metabolism of Propranolol can be increased when combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Propranolol.
Perazine
Perazine may increase the hypotensive activities of Propranolol.
Pergolide
Pergolide may increase the atrioventricular blocking (AV block) activities of Propranolol.
Periciazine
Propranolol may increase the orthostatic hypotensive activities of Propericiazine.
Perindopril
Propranolol may increase the hypotensive activities of Perindopril.
Perphenazine
Perphenazine may increase the hypotensive activities of Propranolol.
Phenelzine
Phenelzine may increase the hypotensive activities of Propranolol.
Phenobarbital
The metabolism of Propranolol can be increased when combined with Phenobarbital.
Phenoxybenzamine
Propranolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Phentolamine
Propranolol may increase the orthostatic hypotensive activities of Phentolamine.
Phentolamine Mesylate
Propranolol may increase the orthostatic hypotensive activities of Phentolamine.
Phenylbutazone
Phenylbutazone may decrease the antihypertensive activities of Propranolol.
Phenylpropanolamine
Propranolol may decrease the bronchodilatory activities of Phenylpropanolamine.
Phenytoin
The metabolism of Propranolol can be increased when combined with Phenytoin.
Physostigmine
Physostigmine may increase the bradycardic activities of Propranolol.
Pilocarpine
The risk or severity of adverse effects can be increased when Propranolol is combined with Pilocarpine.
Pimecrolimus
Pimecrolimus may decrease the antihypertensive activities of Propranolol.
Pinacidil
Pinacidil may increase the hypotensive activities of Propranolol.
Pindolol
Propranolol may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Propranolol.
Pirbuterol
Propranolol may decrease the bronchodilatory activities of Pirbuterol.
Pirfenidone
Pirfenidone may decrease the antihypertensive activities of Propranolol.
Piroxicam
Piroxicam may decrease the antihypertensive activities of Propranolol.
Piroxicam-Beta-Cyclodextrin
Piroxicam may decrease the antihypertensive activities of Propranolol.
Pizotyline
Propranolol may increase the orthostatic hypotensive activities of Pizotifen.
Polythiazide
Propranolol may increase the hypotensive activities of Polythiazide.
Poractant alfa
Propranolol may increase the bradycardic activities of Poractant alfa.
Posaconazole
The metabolism of Propranolol can be decreased when combined with Posaconazole.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Propranolol.
Prazosin
Propranolol may increase the orthostatic hypotensive activities of Prazosin.
Primaquine
The metabolism of Propranolol can be decreased when combined with Primaquine.
Primidone
The metabolism of Propranolol can be increased when combined with Primidone.
Procaine
Procaine may increase the hypotensive activities of Propranolol.
Procarbazine
Procarbazine may increase the hypotensive activities of Propranolol.
Procaterol
Propranolol may decrease the bronchodilatory activities of Procaterol.
Prochlorperazine
Prochlorperazine may increase the hypotensive activities of Propranolol.
Promazine
Propranolol may increase the orthostatic hypotensive activities of Promazine.
Promethazine
Promethazine may increase the hypotensive activities of Propranolol.
Propafenone
The serum concentration of Propranolol can be increased when it is combined with Propafenone.
Propiomazine
Propranolol may increase the orthostatic hypotensive activities of Propiomazine.
Propiverine
Propranolol may increase the orthostatic hypotensive activities of Propiverine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Propranolol.
Proscillaridin
Propranolol may increase the bradycardic activities of Proscillaridin.
Pseudoephedrine
Pseudoephedrine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Pyridostigmine
Pyridostigmine may increase the bradycardic activities of Propranolol.
Pyridostigmine Bromide
Pyridostigmine may increase the bradycardic activities of Propranolol.
Quetiapine
Propranolol may increase the orthostatic hypotensive activities of Quetiapine.
Quetiapine fumarate
Propranolol may increase the orthostatic hypotensive activities of Quetiapine.
Quinapril
Propranolol may increase the hypotensive activities of Quinapril.
Quinidine
The serum concentration of Propranolol can be increased when it is combined with Quinidine.
Quinine
The metabolism of Propranolol can be decreased when combined with Quinine.
Racepinephrine
Propranolol may decrease the bronchodilatory activities of Racepinephrine.
Ramipril
Ramipril may increase the hypotensive activities of Propranolol.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Propranolol.
Rasagiline
Rasagiline may increase the hypotensive activities of Propranolol.
Regorafenib
Regorafenib may increase the bradycardic activities of Propranolol.
Regular Insulin, Human
Propranolol may increase the hypoglycemic activities of Insulin Human.
Remifentanil
Remifentanil may increase the bradycardic activities of Propranolol.
Rescinnamine
Propranolol may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Propranolol.
Resveratrol
Resveratrol may decrease the antihypertensive activities of Propranolol.
Rifabutin
The metabolism of Propranolol can be increased when combined with Rifabutin.
Rifampin
The metabolism of Propranolol can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Propranolol can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Propranolol.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Propranolol.
Riociguat
Propranolol may increase the hypotensive activities of Riociguat.
Risperidone
Propranolol may increase the hypotensive activities of Risperidone.
Ritodrine
Propranolol may decrease the bronchodilatory activities of Ritodrine.
Ritonavir
The metabolism of Propranolol can be decreased when combined with Ritonavir.
Rituximab
Propranolol may increase the hypotensive activities of Rituximab.
Rivastigmine
Propranolol may increase the bradycardic activities of Rivastigmine.
Rizatriptan
The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.
Rofecoxib
Rofecoxib may decrease the antihypertensive activities of Propranolol.
Rolapitant
The metabolism of Propranolol can be decreased when combined with Rolapitant.
Ropinirole
Ropinirole may increase the atrioventricular blocking (AV block) activities of Propranolol.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Propranolol.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Propranolol.
Rucaparib
The metabolism of Propranolol can be decreased when combined with Rucaparib.
Ruxolitinib
Ruxolitinib may increase the bradycardic activities of Propranolol.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Propranolol.
Salicylamide
Salicylamide may decrease the antihypertensive activities of Propranolol.
Salicylic Acid
Salicylic acid may decrease the antihypertensive activities of Propranolol.
Salmeterol
Propranolol may decrease the bronchodilatory activities of Salmeterol.
Salsalate
Salsalate may decrease the antihypertensive activities of Propranolol.
Saquinavir
The metabolism of Propranolol can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Propranolol can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Propranolol can be decreased when used in combination with Sarilumab.
Secobarbital
The serum concentration of Propranolol can be decreased when it is combined with Secobarbital.
Selegiline
Selegiline may increase the hypotensive activities of Propranolol.
Selexipag
Propranolol may increase the hypotensive activities of Selexipag.
Serratiopeptidase
Serrapeptase may decrease the antihypertensive activities of Propranolol.
Sertraline
The metabolism of Propranolol can be decreased when combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Propranolol.
Sildenafil
Sildenafil may increase the antihypertensive activities of Propranolol.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Propranolol.
Siltuximab
The serum concentration of Propranolol can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Propranolol can be increased when it is combined with Simeprevir.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Propranolol.
Spirapril
Propranolol may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Propranolol.
ST. JOHN'S WORT EXTRACT
The serum concentration of Propranolol can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Propranolol.
Sufentanil
Sufentanil may increase the bradycardic activities of Propranolol.
Sulfasalazine
Sulfasalazine may decrease the antihypertensive activities of Propranolol.
Sulfisoxazole
The metabolism of Propranolol can be decreased when combined with Sulfisoxazole.
Sulindac
Sulindac may decrease the antihypertensive activities of Propranolol.
Suprofen
Suprofen may decrease the antihypertensive activities of Propranolol.
Tacrine
Tacrine may increase the bradycardic activities of Propranolol.
Tadalafil
Tadalafil may increase the antihypertensive activities of Propranolol.
Talinolol
Propranolol may increase the hypotensive activities of Talinolol.
Tamsulosin
Propranolol may increase the orthostatic hypotensive activities of Tamsulosin.
Telaprevir
The metabolism of Propranolol can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Propranolol can be decreased when combined with Telithromycin.
Telmisartan
Propranolol may increase the hypotensive activities of Telmisartan.
Tenofovir Disoproxil
The metabolism of Propranolol can be decreased when combined with Tenofovir disoproxil.
Tenoxicam
Tenoxicam may decrease the antihypertensive activities of Propranolol.
Terazosin
Propranolol may increase the orthostatic hypotensive activities of Terazosin.
Terbinafine
The metabolism of Propranolol can be decreased when combined with Terbinafine.
Terbutaline
Propranolol may decrease the bronchodilatory activities of Terbutaline.
Terbutaline Sulfate
Propranolol may decrease the bronchodilatory activities of Terbutaline.
Teriflunomide
The serum concentration of Propranolol can be decreased when it is combined with Teriflunomide.
Terlipressin
Propranolol may increase the hypotensive activities of Terlipressin.
Testosterone Cypionate
Testosterone cypionate may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Propranolol.
Theodrenaline
Propranolol may increase the hypotensive activities of Theodrenaline.
Theophylline
Propranolol may decrease the bronchodilatory activities of Theophylline.
Theophylline anhydrous
Propranolol may decrease the bronchodilatory activities of Theophylline.
Thiamylal
The serum concentration of Propranolol can be decreased when it is combined with Thiamylal.
Thiethylperazine
Thiethylperazine may increase the hypotensive activities of Propranolol.
Thiopental
The serum concentration of Propranolol can be decreased when it is combined with Thiopental.
Thiopental Sodium
The serum concentration of Propranolol can be decreased when it is combined with Thiopental.
Thioproperazine
Propranolol may increase the orthostatic hypotensive activities of Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Propranolol.
Tiaprofenic Acid
Tiaprofenic acid may decrease the antihypertensive activities of Propranolol.
Tibolone
Propranolol may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Propranolol can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypotensive activities of Propranolol.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Propranolol.
Tipranavir
The metabolism of Propranolol can be decreased when combined with Tipranavir.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Propranolol.
Tocilizumab
The serum concentration of Propranolol can be decreased when it is combined with Tocilizumab.
Tofacitinib
Tofacitinib may increase the bradycardic activities of Propranolol.
Tolazamide
Propranolol may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Propranolol may increase the orthostatic hypotensive activities of Tolazoline.
Tolbutamide
Propranolol may increase the hypoglycemic activities of Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Propranolol.
Tolfenamic Acid
Tolfenamic Acid may decrease the antihypertensive activities of Propranolol.
Tolmetin
Tolmetin may decrease the antihypertensive activities of Propranolol.
Toloxatone
Toloxatone may increase the hypotensive activities of Propranolol.
Topiramate
The metabolism of Propranolol can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Propranolol.
Torsemide
Torasemide may increase the hypotensive activities of Propranolol.
Trandolapril
Trandolapril may increase the hypotensive activities of Propranolol.
Tranilast
Tranilast may decrease the antihypertensive activities of Propranolol.
Tranylcypromine
The metabolism of Propranolol can be decreased when combined with Tranylcypromine.
Travoprost
Travoprost may increase the hypotensive activities of Propranolol.
Trazodone
Propranolol may increase the orthostatic hypotensive activities of Trazodone.
Treprostinil
Treprostinil may increase the hypotensive activities of Propranolol.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Propranolol.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Propranolol.
Tribenoside
Tribenoside may decrease the antihypertensive activities of Propranolol.
Trichlormethiazide
Propranolol may increase the hypotensive activities of Trichlormethiazide.
Trifluoperazine
Propranolol may increase the orthostatic hypotensive activities of Trifluoperazine.
Triflupromazine
Triflupromazine may increase the hypotensive activities of Propranolol.
Trimeprazine
Alimemazine may increase the hypotensive activities of Propranolol.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Propranolol.
Trimipramine
Propranolol may increase the orthostatic hypotensive activities of Trimipramine.
Tubocurarine
Tubocurarine may increase the bradycardic activities of Propranolol.
Tyrothricin
Tyrothricin may increase the bradycardic activities of Propranolol.
UNOPROSTONE
Propranolol may increase the hypotensive activities of Unoprostone.
Urapidil
Propranolol may increase the orthostatic hypotensive activities of Urapidil.
Valdecoxib
Valdecoxib may decrease the antihypertensive activities of Propranolol.
Valsartan
Valsartan may increase the hypotensive activities of Propranolol.
Vardenafil
Vardenafil may increase the antihypertensive activities of Propranolol.
Varenicline
The risk or severity of adverse effects can be increased when Propranolol is combined with Varenicline.
Vemurafenib
The serum concentration of Propranolol can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Propranolol can be decreased when combined with Venlafaxine.
Verapamil
Propranolol may increase the orthostatic hypotensive activities of Verapamil.
Vilanterol
Propranolol may decrease the bronchodilatory activities of Vilanterol.
Vincamine
Propranolol may increase the hypotensive activities of Vincamine.
Vincristine
The excretion of Vincristine can be decreased when combined with Propranolol.
Vinpocetine
Propranolol may increase the hypotensive activities of Vinpocetine.
Voriconazole
The metabolism of Propranolol can be decreased when combined with Voriconazole.
Xylazine
Xylazine may increase the atrioventricular blocking (AV block) activities of Propranolol.
Xylometazoline
Xylometazoline may increase the atrioventricular blocking (AV block) activities of Propranolol.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Propranolol.
Zileuton
The serum concentration of Propranolol can be increased when it is combined with Zileuton.
Ziprasidone
Propranolol may increase the orthostatic hypotensive activities of Ziprasidone.
Zofenopril
Propranolol may increase the hypotensive activities of Zofenopril.
Zolmitriptan
The serum concentration of Zolmitriptan can be increased when it is combined with Propranolol.
Zomepirac
Zomepirac may decrease the antihypertensive activities of Propranolol.
Zuclopenthixol
Propranolol may increase the orthostatic hypotensive activities of Zuclopenthixol.
